Lanlay Natural Herbal Laxalite
Natural health product licensed in Canada
- Licence holder
- Lanlay Healthmetic Inc.
- NPN or DIN-HM
- 80113954
- Status
- Active licence
- Licence date
- 4 November 2021
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trichosanthes kirilowii Maxim.: L'absence de trichosanthine doit être prouvée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Rheum palmatum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dioscorea oppositifolia Source : Rhizome Extract : Matériel brut sec Extraction ratio : 13:1 Dry plant equivalent : 118.3 mg | 9.1 mg | Not calculated |
| Citrus aurantium Source : Fruit Extract : Matériel brut sec Extraction ratio : 4.971:1 Dry plant equivalent : 118.3 mg | 23.8 mg | Not calculated |
| Trichosanthes kirilowii Source : Graine Extract : Matériel brut sec Extraction ratio : 4.971:1 Dry plant equivalent : 118.3 mg | 23.8 mg | Not calculated |
| Magnolia officinalis Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 7.342:1 Dry plant equivalent : 118.2 mg | 16.1 mg | Not calculated |
| Cannabis sativa Source : Graine Extract : Matériel brut sec Extraction ratio : 14:1 Dry plant equivalent : 236.6 mg | 16.9 mg | Not calculated |
| Rheum palmatum Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 6.221:1 Dry plant equivalent : 118.2 mg | 19 mg | Not calculated |
| Prunus persica Source : Graine Extract : Matériel brut sec Extraction ratio : 8.509:1 Dry plant equivalent : 197.4 mg | 23.2 mg | Not calculated |
| Nelumbo nucifera Source : Feuille Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 118.4 mg | 14.8 mg | Not calculated |
| Reynoutria multiflora Source : Tubercule Extract : Matériel brut sec Extraction ratio : 7.461:1 Dry plant equivalent : 250.7 mg | 33.6 mg | Not calculated |
| Ophiopogon japonicus Source : Tubercule Extract : Matériel brut sec Extraction ratio : 5.97:1 Dry plant equivalent : 118.2 mg | 19.8 mg | Not calculated |
| Cistanche deserticola Source : Tige Extract : Matériel brut sec Extraction ratio : 5.519:1 Dry plant equivalent : 118.1 mg | 21.4 mg | Not calculated |
| Saussurea costus Source : Racine Extract : Matériel brut sec Extraction ratio : 5.97:1 Dry plant equivalent : 59.1 mg | 9.9 mg | Not calculated |
| Angelica sinensis Source : Racine Extract : Matériel brut sec Extraction ratio : 2.599:1 Dry plant equivalent : 59 mg | 22.7 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 6 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients. He shou wu/ Reynoutria multiflora is used in Traditional Chinese Medicine (TCM) to clear toxic heat, moisten the Intestines and open the bowels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80113954
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.